Antibodies are Y-shaped glycoproteins composed of two heavy chains (50–70 kDa) and two light chains (25 kDa), with variable regions (Fv) responsible for antigen binding and constant regions (Fc) mediating effector functions . The Fc region interacts with complement proteins and immune cells, while the Fv contains complementarity-determining regions (CDRs) that determine specificity .
Abs-9: A human IgG1 antibody targeting Staphylococcus aureus protein A (SpA5) exhibits nanomolar affinity (KD = 1.96 × 10⁻⁹ M) and protects against lethal doses of antibiotic-resistant strains in mice . Its epitope spans 36 amino acids on SpA5, validated via molecular docking and ELISA .
24D11: A murine IgG2b antibody targeting carbapenem-resistant Klebsiella pneumoniae capsular polysaccharide (CPS) demonstrates cross-protection against three CPS types (wzi29, wzi154, wzi50) in both in vitro and in vivo models .
23ME-00610: A humanized IgG1 antibody targeting CD200R1 enhances T-cell function by blocking the CD200:CD200R1 immune checkpoint. It achieves high affinity (KD < 0.1 nM) and promotes tumor cell killing in melanoma models .
RA9-23: A directed-evolved antibody targeting cancer-associated glycosylation (CA19-9) shows improved binding to pancreatic and colon cancer cells, with enhanced complement-dependent cytotoxicity (CDC) .
Commercial antibodies require rigorous validation for specificity and efficacy. For example:
Anti-CSPα: Detects endogenous CSPα at 35 kDa in Western blot (PC12, COS7, SHSY5Y cells) .
Anti-SNAP25 (MAB331): Exhibits specific staining in PC12 cells but cross-reactivity in COS7 cells .
Custom antibody development involves hybridoma fusion, recombinant expression, or single-cell RNA/VDJ sequencing to identify clonotypes .
Literature Search: Check recent publications (2023–2025) in journals like Nature Biotechnology or Cancer Research for mentions of SPAC23C4.09c.
Clinical Trial Databases: Review ClinicalTrials.gov for ongoing trials involving this antibody.
Patent Databases: Search the World Intellectual Property Organization (WIPO) or USPTO for filings related to SPAC23C4.09c.
Direct Manufacturer Inquiry: Contact the developer (e.g., biotech companies like Antibody Research Corporation ) for technical data sheets or preprints.
SPAC23C4.09c is a gene in Schizosaccharomyces pombe (fission yeast) that encodes a DNA-binding TFAR19-related protein. It has attracted research interest due to its predicted role in transcriptional regulation and DNA-binding functions . Studies have shown that this gene is involved in cellular responses to various conditions, including nitrogen starvation, as evidenced by gene expression data showing downregulation under nitrogen-deficient conditions . Research into SPAC23C4.09c contributes to our understanding of fundamental cellular processes in eukaryotic organisms, making it valuable for comparative genomics and evolutionary studies.
Commercial SPAC23C4.09c antibodies, such as those produced by CUSABIO-WUHAN HUAMEI BIOTECH Co., Ltd., are developed with high specificity for the target protein . The specificity is typically verified through multiple validation methods including Western blotting, immunoprecipitation, and immunofluorescence in S. pombe cells. When selecting an antibody for research, it's advisable to review the validation data provided by manufacturers and consider antibodies that have been cited in peer-reviewed publications. For optimal specificity, researchers should also perform their own validation experiments using positive controls (S. pombe extracts) and negative controls (extracts from deletion strains or non-related species) to confirm antibody performance in their specific experimental conditions.
SPAC23C4.09c antibodies are commonly employed in several key applications:
Western blotting: For detection and quantification of SPAC23C4.09c protein expression levels
Immunoprecipitation (IP): To study protein-protein interactions
Chromatin immunoprecipitation (ChIP): To investigate DNA-protein interactions, particularly relevant given the DNA-binding properties of SPAC23C4.09c
Immunofluorescence: To determine subcellular localization
Flow cytometry: For quantitative analysis in cell populations
These applications have been instrumental in studies examining transcriptional responses during cellular stress, particularly in nitrogen starvation conditions where SPAC23C4.09c shows significant expression changes .
For optimal Western blotting with SPAC23C4.09c antibodies:
Sample preparation protocol:
Harvest S. pombe cells (OD₆₀₀ of 0.5-0.8) by centrifugation
Wash with ice-cold water
Resuspend in lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM MgCl₂, 1% Triton X-100, protease inhibitor cocktail)
Centrifuge at 13,000 g for 15 minutes at 4°C
Collect supernatant and determine protein concentration
Western blotting conditions:
Protein loading: 20-50 μg per lane
Primary antibody dilution: 1:1000 (optimize based on specific antibody)
Incubation: Overnight at 4°C or 2 hours at room temperature
Secondary antibody: Anti-species IgG-HRP (1:5000)
Detection: Enhanced chemiluminescence (ECL)
For validation, include positive controls (wild-type S. pombe extracts) and negative controls (deletion strains). Researchers should note that cross-reactivity can occur with related proteins, so additional controls may be necessary to ensure specificity .
ChIP experiments with SPAC23C4.09c antibodies should follow this methodological approach:
Crosslinking: Treat S. pombe cells with 1% formaldehyde for 15 minutes at room temperature, followed by quenching with 125 mM glycine
Cell lysis: Use glass bead disruption in lysis buffer containing protease inhibitors
Chromatin preparation: Sonicate to achieve fragments of 200-500 bp
Immunoprecipitation:
Pre-clear chromatin with protein A/G beads
Incubate with 2-5 μg SPAC23C4.09c antibody overnight at 4°C
Add protein A/G beads and incubate for 2-3 hours
Wash extensively with increasingly stringent buffers
Reverse crosslinking: Heat at 65°C overnight
DNA purification: Use commercial kits or phenol-chloroform extraction
Analysis: Perform qPCR or next-generation sequencing
Based on studies of similar DNA-binding proteins in S. pombe, researchers might expect enrichment of SPAC23C4.09c at specific genomic loci, particularly during stress conditions. The ChIP-chip approach described in provides a valuable reference methodology for genome-wide analysis.
When conducting immunoprecipitation with SPAC23C4.09c antibodies, the following controls are essential:
Essential controls:
Input control: Sample of the extract before immunoprecipitation (5-10%)
No-antibody control: Beads only, to detect non-specific binding
Isotype control: Irrelevant antibody of the same isotype
Genetic controls: SPAC23C4.09c deletion strain extracts (negative control)
Tagged protein control: If available, a strain expressing tagged SPAC23C4.09c (e.g., TAP-tagged or GFP-tagged as described in )
Validation approach:
Western blot a portion of the immunoprecipitated material to confirm enrichment
Mass spectrometry analysis can identify interacting partners
Reciprocal co-IP experiments with antibodies against suspected interacting proteins
Research has demonstrated that appropriate controls are critical for distinguishing true interactions from background, especially when studying DNA-binding proteins like SPAC23C4.09c that might be part of larger complexes .
Computational epitope prediction for SPAC23C4.09c can significantly enhance antibody specificity:
Computational approach workflow:
Structural prediction: Use homology modeling tools like RosettaAntibody to predict the 3D structure of SPAC23C4.09c if experimental structures are unavailable
Epitope prediction: Apply algorithms that consider:
Surface accessibility
Hydrophilicity
Antigenicity
Secondary structure
Conservation analysis (comparing orthologues)
Antibody design: Use platforms like IsAb protocol to design antibodies targeting the predicted epitopes
A computational study by Desautels et al. demonstrated that machine learning and molecular dynamics simulations can guide antibody design with improved specificity and affinity, reducing the need for extensive experimental screening . The RosettaAntibodyDesign (RAbD) framework offers particular promise for designing antibodies with optimized binding properties .
Example of computational pipeline for antibody design:
| Step | Method | Software/Tool | Output |
|---|---|---|---|
| 1 | Structure prediction | RosettaAntibody | 3D model of SPAC23C4.09c |
| 2 | Epitope prediction | IEDB, Discotope, BepiPred | Ranked list of likely epitopes |
| 3 | Antibody sequence design | RAbD, IsAb protocol | Candidate antibody sequences |
| 4 | Binding affinity prediction | FoldX, Rosetta | Predicted binding energies |
| 5 | Molecular dynamics simulation | MM/GBSA | Refined binding predictions |
This approach can reduce development time and improve antibody performance by focusing experimental efforts on computationally validated candidates .
Cross-reactivity can be a significant challenge when using SPAC23C4.09c antibodies, especially when the target protein participates in multi-protein complexes. Several advanced strategies can address this issue:
Epitope mapping and antibody engineering:
Determine the exact epitope recognized by the antibody through peptide arrays or hydrogen-deuterium exchange mass spectrometry
Redesign antibodies to target unique regions of SPAC23C4.09c using in silico approaches
Apply negative selection against potential cross-reactive proteins during antibody development
Experimental validation strategies:
Super-resolution microscopy: To visualize spatial separation of potentially cross-reacting proteins
Proximity ligation assays (PLA): To verify protein interactions with high specificity
Parallel reaction monitoring (PRM): For mass spectrometry-based validation
Advanced biochemical approaches:
Sequential immunoprecipitation to dissect complex composition
Chemical crosslinking followed by mass spectrometry (XL-MS) to map protein interfaces
Competition assays with purified proteins to test specificity
Research by Zemla et al. demonstrates how computational approaches can predict antibody structures capable of distinguishing between highly similar targets, which could be applied to improve SPAC23C4.09c antibody specificity .
SPAC23C4.09c shows significant expression changes during nitrogen starvation (based on microarray data in ), making it an interesting target for studying protein dynamics under these conditions:
Experimental approach:
Time-course sampling: Collect S. pombe cells at defined intervals after nitrogen depletion (0, 1, 2, 4, 6, 8 hours as in )
Protein extraction and quantification: Use standardized protocols with appropriate normalization controls
Multiple analytical methods:
Western blotting for total protein levels
Cellular fractionation to monitor subcellular redistribution
ChIP-seq to track DNA binding site occupancy changes
Co-IP to identify stress-specific interaction partners
Phospho-specific antibodies (if available) to monitor post-translational modifications
Data analysis framework:
Correlation of protein dynamics with transcriptional data
Integration with other 'omics datasets (metabolomics, proteomics)
Network analysis of changing protein-protein interactions
Based on the expression data in , you would expect to observe:
| Time (hours) | Expression change (-N+P) | Expression change (-N-P) | Expected protein level change |
|---|---|---|---|
| 0 | 0.000 | 0.000 | Baseline |
| 1 | -1.425 | -1.558 | Significant decrease |
| 2 | -1.075 | -1.630 | Continued decrease |
| 3 | -1.265 | -1.042 | Sustained low levels |
| 4 | -1.014 | -0.924 | Slight recovery |
| 5 | -0.818 | -0.725 | Gradual recovery |
| 6 | -0.875 | -0.690 | Stabilization at lower than baseline |
| 7 | -0.644 | -0.747 | Stabilization at lower than baseline |
| 8 | -0.828 | -0.681 | Stabilization at lower than baseline |
This approach would provide insights into the role of SPAC23C4.09c in stress response pathways and adaptation mechanisms .
Inconsistent results with SPAC23C4.09c antibodies can stem from several sources:
Common issues and solutions:
| Issue | Possible Causes | Recommended Solutions |
|---|---|---|
| Weak or no signal | - Low expression level - Protein degradation - Antibody degradation - Epitope masking | - Increase sample concentration - Add protease inhibitors - Store antibody properly (aliquot, -20°C) - Try different extraction methods |
| Non-specific bands | - Cross-reactivity - Secondary antibody issues - Protein modifications | - Increase washing stringency - Use monoclonal antibodies - Include additional controls - Pre-absorb antibody with non-specific proteins |
| Variable results between experiments | - Cell culture conditions - Extraction efficiency - Antibody batch variation | - Standardize growth conditions - Use internal loading controls - Test new antibody lots against old ones |
| Background in imaging | - Fixation artifacts - Autofluorescence - Non-specific binding | - Optimize fixation protocol - Include proper blocking steps - Use confocal microscopy with narrow bandpass filters |
Advanced troubleshooting:
Epitope mapping: Identify precisely which part of SPAC23C4.09c the antibody recognizes
Post-translational modifications: Consider whether modifications affect antibody recognition
Protein complexes: Determine if protein-protein interactions mask the epitope
Sample preparation variations: Test multiple extraction methods to optimize epitope exposure
A systematic approach to troubleshooting, as demonstrated in research on other S. pombe proteins , can significantly improve experimental consistency.
Interpreting changes in SPAC23C4.09c localization during stress requires careful consideration of several factors:
Interpretation framework:
Baseline localization: First establish the normal subcellular distribution of SPAC23C4.09c under non-stress conditions
Stress-induced changes: Changes might include:
Nuclear-cytoplasmic shuttling
Association with specific nuclear subcompartments
Co-localization with stress granules or other stress-responsive structures
Temporal dynamics: Distinguish between:
Immediate responses (minutes)
Intermediate responses (hours)
Adaptive responses (days)
Co-localization analysis: Examine relationship with:
DNA (DAPI staining)
Nuclear substructures (nucleolus, Cajal bodies)
Stress-responsive factors (heat shock proteins, stress granules)
Functional correlation: Connect localization changes to:
Transcriptional changes (RNA-seq data)
Protein-protein interactions (co-IP data)
Post-translational modifications
Studies with other nuclear proteins in S. pombe have shown that translocation can be a key regulatory mechanism during stress responses . Advanced imaging techniques, combined with genetic manipulations (e.g., deletion of interaction partners), can provide mechanistic insights into the functional significance of these localization changes.
Accurate quantification of SPAC23C4.09c protein levels in comparative studies requires rigorous methodological approaches:
Quantification best practices:
Sample normalization strategies:
Total protein normalization (preferred): Use stain-free gels or total protein stains
Housekeeping protein controls: Use multiple references (e.g., actin, GAPDH)
Spike-in standards: Add known quantities of recombinant proteins
Quantitative Western blotting:
Use a standard curve with recombinant protein
Ensure linearity of detection (verify with dilution series)
Use digital imaging systems rather than film
Perform technical replicates (minimum 3)
Include biological replicates (minimum 3)
Alternative quantification methods:
ELISA for higher throughput and sensitivity
Mass spectrometry for absolute quantification (using AQUA peptides)
Flow cytometry for single-cell analysis (if antibody works in flow)
Statistical analysis:
Apply appropriate statistical tests (t-test, ANOVA)
Report effect sizes, not just p-values
Include power analysis to determine sample size
Account for batch effects in experimental design
These approaches ensure reliable quantification while minimizing technical and biological variability, as demonstrated in studies of other S. pombe proteins .
Computational antibody design is revolutionizing the development of highly specific antibodies, including those targeting proteins like SPAC23C4.09c:
Current computational approaches:
Structure-based design: The IsAb computational protocol provides a systematic workflow for antibody design, starting with structural prediction and proceeding through docking, hotspot identification, and affinity maturation . This approach can be applied to design antibodies specifically targeting unique epitopes of SPAC23C4.09c.
Machine learning integration: Recent advances combine structural modeling with machine learning to predict antibody-antigen interactions more accurately. The approach described by Desautels et al. demonstrated that machine learning algorithms could predict mutations that improve binding affinity, with calculated improvements in interaction energy from -48.1 kcal/mol to as low as -82.0 kcal/mol .
High-performance computing: The use of supercomputing resources has enabled more comprehensive exploration of the vast sequence space for antibody design. One study performed 178,856 in silico free energy calculations for 89,263 mutant antibodies in just 22 days .
Multi-scale modeling: Integrating atomic-level dynamics with coarse-grained models allows for more accurate prediction of antibody-antigen interactions across different time scales and physical contexts.
Recent breakthroughs in RosettaAntibodyDesign (RAbD) provide a general framework for computational antibody design that could be applied to develop highly specific SPAC23C4.09c antibodies with optimized binding properties .
Several cutting-edge techniques are improving both specificity and sensitivity in antibody-based experiments:
Emerging techniques:
Single-molecule detection methods:
Single-molecule pull-down (SiMPull) combines single-molecule fluorescence with traditional pull-down assays
Total internal reflection fluorescence (TIRF) microscopy enables detection of individual protein molecules
These approaches could detect low-abundance forms of SPAC23C4.09c with higher sensitivity
Proximity-based labeling:
BioID or APEX2 fusion proteins can be used to identify proteins in close proximity to SPAC23C4.09c
This approach maps the protein's microenvironment without relying solely on antibody specificity
Nanobody and single-domain antibody technologies:
Antibody-guided small molecule mimetics:
CRISPR-based tagging:
Endogenous tagging of SPAC23C4.09c via CRISPR/Cas9 allows antibody-independent detection
This approach ensures physiological expression levels and localization
These technologies are expanding the toolkit available for studying SPAC23C4.09c and similar proteins, enabling more precise spatial and temporal resolution of protein dynamics.
SPAC23C4.09c antibodies can provide valuable insights into the evolutionary conservation of transcriptional regulation mechanisms:
Research applications in evolutionary studies:
Cross-species comparative analysis:
Testing for cross-reactivity with orthologous proteins in related yeast species
Examining conservation of protein-protein interactions across species
Comparing post-translational modification patterns between evolutionary distant organisms
Functional conservation studies:
ChIP-seq to map binding sites across species
Analysis of protein dynamics during conserved cellular processes
Complementation studies with orthologs from different species
Structural conservation investigation:
Epitope conservation analysis across species
Mapping of functionally constrained domains versus rapidly evolving regions
Correlation between structural and functional conservation
Regulatory network evolution:
Identification of conserved versus species-specific interaction partners
Mapping evolutionary changes in transcriptional responses
Tracing the evolution of stress response pathways
These approaches can reveal fundamental principles of transcriptional regulation that have been maintained throughout eukaryotic evolution, as well as lineage-specific adaptations. The study of SPAC23C4.09c as a DNA-binding TFAR19-related protein offers a window into the evolution of transcriptional regulatory networks in eukaryotes .